News
Sound Pharmaceuticals to launch NIH-funded Covid-19 oral therapeutic trial
Developed for various neurotologic, neuropsychiatric, and respiratory indications, SPI-1005 is a capsule with a small molecule called ebselen.
The latest development comes after Sound Pharmaceuticals received a Cooperative Grant award worth $3.1m from the US National Institutes of Health (NIH)...
News
UK begins rollout of Moderna vaccine against COVID-19 in Wales
Moderna’s Covid-19 vaccine rollout has begun in the UK, where patients in Wales have been the first to receive a dose. Supplies arrived in Wales with 5,000 doses having been delivered to vaccination centres across Carmarthenshire, Ceredigion and Pembrokeshire....
News
Peli BioThermal Adds Module in School of Cool Online Learning Platform
Peli BioThermal, the global name in temperature controlled solutions, announces a new module available now on its School of Cool™ online learning platform. The newest module available in the platform introduces customers and distributors to reusable and single-use shippers,...
News
Hitachi and Axcelead to start joint development of solutions for the efficient creation of next-generation biopharmaceuticals
Hitachi, Ltd. announced that they have agreed on a comprehensive collaborative partnership to develop solutions contributing on more efficient creation of next-generation biopharmaceuticals with digital technology and drug discovery platform. Hitachi has also made investment to Drug Discovery Gateway...
News
AB Science and University of Chicago to develop Covid-19 drugs
AB Science SA, together with the University of Chicago, announces the signing of an exclusive licensing agreement for conducting research on the prevention and treatment of humans infected with nidoviruses, coronaviruses and picornaviruses.
This collaboration follows the discovery by the...
News
Oxford Pauses Dosing in Trial of AstraZeneca Covid-19 Vaccine in Children, Teenagers
The University of Oxford said that it had paused a small UK trial testing the COVID-19 vaccine it developed with AstraZeneca Plc in children and teenagers, as it waits for more data on rare blood clotting issues in adults...
News
Sterling Pharma Solutions acquires ADC Bio
Global contract development and manufacturing organisation (CDMO), Sterling Pharma Solutions, has announced the acquisition of ADC Biotechnology, a UK based bioconjugation development services business specialising in antibody drug conjugates (ADCs).
This follows an announcement by Sterling in December of a...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
















